These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9293446)

  • 1. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
    Pietsch T; Koch A; Wiestler OD
    Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma.
    Kraus JA; Koch A; Albrecht S; Von Deimling A; Wiestler OD; Pietsch T
    Int J Cancer; 1996 Jul; 67(1):11-5. PubMed ID: 8690510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas.
    Koch A; Tonn J; Kraus JA; Sorensen N; Albrecht NS; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):233-42. PubMed ID: 8804025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
    Emadian SM; McDonald JD; Gerken SC; Fults D
    Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.
    Schofield D; West DC; Anthony DC; Marshal R; Sklar J
    Am J Pathol; 1995 Feb; 146(2):472-80. PubMed ID: 7856756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.
    Biegel JA; Burk CD; Barr FG; Emanuel BS
    Cancer Res; 1992 Jun; 52(12):3391-5. PubMed ID: 1596898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
    Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
    J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs.
    Frühwald MC; O'Dorisio MS; Dai Z; Rush LJ; Krahe R; Smiraglia DJ; Pietsch T; Elsea SH; Plass C
    Genes Chromosomes Cancer; 2001 Jan; 30(1):38-47. PubMed ID: 11107174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
    Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
    Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.
    Thomas GA; Raffel C
    Cancer Res; 1991 Jan; 51(2):639-43. PubMed ID: 1670763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas.
    Albrecht S; von Deimling A; Pietsch T; Giangaspero F; Brandner S; Kleihues P; Wiestler OD
    Neuropathol Appl Neurobiol; 1994 Feb; 20(1):74-81. PubMed ID: 8208343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent p53 gene mutations in medulloblastomas.
    Saylors RL; Sidransky D; Friedman HS; Bigner SH; Bigner DD; Vogelstein B; Brodeur GM
    Cancer Res; 1991 Sep; 51(17):4721-3. PubMed ID: 1873817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
    Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
    Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.